LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma
Condition: Advanced Soft-tissue Sarcoma Intervention: Drug: Lurbinectedin Sponsor: ERLINDA M GORDON Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 25, 2023 Category: Research Source Type: clinical trials
Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People > = 18 Years Old With Advanced Soft Tissue Sarcoma
Conditions: Metastatic Extraskeletal Myxoid Chondrosarcoma; Metastatic Leiomyosarcoma; Metastatic Liposarcoma; Metastatic Undifferentiated Pleomorphic Sarcoma Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Drug: Cabozantinib; Procedure: Computed Tomography; Biological: Ipilimumab; Procedure: Magnetic Resonance Imaging; Biological: Nivolumab Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2023 Category: Research Source Type: clinical trials